Literature DB >> 9419900

Chrysin and other leaf exudate flavonoids in the genus Pelargonium.

C A Williams1, J B Harborne, M Newman, J Greenham, J Eagles.   

Abstract

In a chemotaxonomic survey of 57 Pelargonium species, leaf exudate flavonoids were detected in 35% of the sample, mostly in trace amounts. However, chrysin and a related C-methylflavanone were identified as major leaf surface constituents of P. crispum, and a mixture of quercetin and kaempferol mono-, and di- and trimethyl ethers of P. quercifolium. In two other species, P. fulgidum and P. exstipulatum, methylated flavones were the only lipophilic flavonoids present. This is the first report of leaf surface flavonoids from the genus Pelargonium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9419900     DOI: 10.1016/s0031-9422(97)00514-1

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  16 in total

1.  Short-term exposure to chrysin promotes proliferative responses in the ventral male prostate and female prostate of adult gerbils.

Authors:  Mônica S Campos; João P A Silva; Danilo S Lima; Luis O Regasini; Mara Rúbia Marques; Manoel F Biancardi; Sebastião R Taboga; Fernanda C A Santos
Journal:  Int J Exp Pathol       Date:  2019-05-26       Impact factor: 1.925

2.  The Protective Effect of Chrysin Against Cisplatin İnduced Ototoxicity in Rats.

Authors:  Mehmet Kelles; Mehmet Tan; M Tayyar Kalcioglu; Yuksel Toplu; Nazire Bulam
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-11-28

3.  Chrysin impairs genomic stability by suppressing DNA double-strand break repair in breast cancer cells.

Authors:  Anke Geng; Shiya Xu; Yunxia Yao; Zhen Qian; Xiyue Wang; Jiahui Sun; Jingyuan Zhang; Fangfang Shi; Zhixi Chen; Weina Zhang; Zhiyong Mao; Wen Lu; Ying Jiang
Journal:  Cell Cycle       Date:  2022-01-05       Impact factor: 4.534

Review 4.  Anti-ovarian cancer potential of phytocompound and extract from South African medicinal plants and their role in the development of chemotherapeutic agents.

Authors:  Chella Perumal Palanisamy; Bo Cui; Hongxia Zhang; Mani Panagal; Sivagurunathan Paramasivam; Uma Chinnaiyan; Selvaraj Jeyaraman; Karthigeyan Murugesan; Mauricio Rostagno; Vijayakumar Sekar; Srinivasa Prabhu Natarajan
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

5.  Chrysin reduced acrylamide-induced neurotoxicity in both in vitro and in vivo assessments.

Authors:  Soghra Mehri; Hamed Veis Karami; Faezeh Vahdati Hassani; Hossein Hosseinzadeh
Journal:  Iran Biomed J       Date:  2014

6.  Antihypercholesterolemic and antioxidative effects of an extract of the oyster mushroom, Pleurotus ostreatus, and its major constituent, chrysin, in Triton WR-1339-induced hypercholesterolemic rats.

Authors:  Ramalingam Anandhi; Thangaraj Annadurai; Thirugnanasambandhar S Anitha; Arumugam R Muralidharan; Kalifulla Najmunnisha; Vasanthi Nachiappan; Philip A Thomas; Pitchairaj Geraldine
Journal:  J Physiol Biochem       Date:  2012-10-27       Impact factor: 4.158

7.  Evaluation of the anti-atherogenic potential of chrysin in Wistar rats.

Authors:  Ramalingam Anandhi; Philip A Thomas; Pitchairaj Geraldine
Journal:  Mol Cell Biochem       Date:  2013-09-25       Impact factor: 3.396

8.  Chrysin ameliorates diabetes-associated cognitive deficits in Wistar rats.

Authors:  Rui Li; Aihua Zang; Lei Zhang; Huiyun Zhang; Longshan Zhao; Zhonghua Qi; Hui Wang
Journal:  Neurol Sci       Date:  2014-04-16       Impact factor: 3.307

9.  Effects of chrysin (5,7-dihydroxyflavone) on vascular remodeling in hypoxia-induced pulmonary hypertension in rats.

Authors:  Xian-Wei Li; Xiang-Ming Wang; Shu Li; Jie-Ren Yang
Journal:  Chin Med       Date:  2015-02-18       Impact factor: 5.455

10.  5,7-Dihydroxyflavone Enhances the Apoptosis-Inducing Potential of TRAIL in Human Tumor Cells via Regulation of Apoptosis-Related Proteins.

Authors:  Zhenzhen Zhang; Tingmei Ye; Xueting Cai; Jie Yang; Wuguang Lu; Chunping Hu; Zhigang Wang; Xiaoning Wang; Peng Cao
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.